Top Markets
#1 DogBull DogBull +54.73%
#2 Siren Siren +31.33%
#3 OriginTrail OriginTrail +17.13%
#4 龙虾 (Lobster) 龙虾 (Lobster) +9.48%
#5 Yield Basis Yield Basis +9.42%
#6 Verus Coin Verus Coin +7.40%
#7 Stargate Finance Stargate Finance +7.16%
#8 Collect on Fanable Collect on Fanable +6.91%
#9 LayerZero LayerZero +6.90%
#10 COTI COTI +6.55%
Coin of the day
DogBull DogBull
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
AlzeCure Pharma AB AlzeCure Pharma AB

AlzeCure Pharma AB

ALZCUR
Clasificación en acciones #22112
AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops... AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are in preclinical trial for the treatment of Alzheimer’s disease; ACD440, a TRPV1 antagonist that has completed phase I clinical trial for neuropathic pain indications; and ACD137, negative allosteric modulator (NAM) of TrkA receptors for osteoarthritic pain indications. The company was founded in 2012 and is based in Huddinge, Sweden.
Precio por acción
$0.71707249
Última sincronización: 2026-08-21
Capitalización bursátil
$94.14M
Cambio (1 día)
-3.31%
Cambio (1 año)
76.82%
País
SE
Comercio AlzeCure Pharma AB (ALZCUR)

Categoría

Healthcare
Ingresos de AlzeCure Pharma AB (ALZCUR)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de AlzeCure Pharma AB, los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de AlzeCure Pharma AB desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH